HORIZON EUROPE – Supporting the implementation of the Cancer Mission – 2027

2027-09-21
115.32 million euros
Opening 10/02/2027
Upcoming

Call synthesis

Call reference HORIZON-MISS-2027-02
Programme HORIZON EUROPE
Institution European Commission
Sectors Health Research & Innovation Technology & Digital
Beneficiaries Association & NGO Large company (> 250 employees) Research centre & university Smes & Start-Ups (< 249 Employees) State administration & affiliated entities

Content reserved for subscribers

Call reference

HORIZON-MISS-2027-02



Register for free to access the content

Free access to all information

Priorities and funded actions

Some Horizon Europe budgets are structured in response to policy ambitions (“destinations”) and deployed through calls for proposals targeting more specific thematic/sector (“Topics”). Thus, your application must be linked to a topic of a call for proposals.

Various categories of projects are eligible:

  • RIA, Research and Innovation Actions: Basic and applied research / Technology development and adoption / Testing and validation of a prototype in the laboratory
  • IA, Innovation Actions: Prototypes, tests, demonstrations, pilot projects, market placement. These actions may include limited R&D activities
  • CSA, Coordination and Support Actions: Networking, studies & conferences, communication, studies for new research infrastructures
  • MSCA, Marie Skłodowska-Curie Actions / ERC individual grants: Training networks for researchers, Individual grants for experienced researchers, Staff exchange – mobility for researchers and non-scientific staff

In addition, calls specify the categories of eligible beneficiaries:

  • Collaborative projects, composed of a coordinator and several partners organisations (consortium)
  • Single-beneficiary projects, involving a single organization
  • Individual scholarships, open to natural persons in their own name with their home institution

Topics

Forthcoming

  • HORIZON-MISS-2027-02-CANCER-01: Leveraging functional genomics to reveal novel targets for cancer treatment
  • HORIZON-MISS-2027-02-CANCER-02: Clinical research by Comprehensive Cancer Infrastructures for the benefit of patients with common cancers
  • HORIZON-MISS-2027-02-CANCER-03: Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes
  • HORIZON-MISS-2027-02-CANCER-04: Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research
  • HORIZON-MISS-2027-02-CANCER-05: Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines
  • HORIZON-MISS-2027-02-CANCER-06: Support a Young Cancer Survivor Quality of Life (QoL) research programme by cancer charities and funding agencies

Additional information

  • To find your National Contact Point (NCP): Click here

Useful

Financement
  • Total budget of the call: 115.32 million euros
  • Budget per topic:
    • HORIZON-MISS-2027-02-CANCER-01: 32.32 million euros
    • HORIZON-MISS-2027-02-CANCER-02: 20 million euros
    • HORIZON-MISS-2027-02-CANCER-03: 24 million euros
    • HORIZON-MISS-2027-02-CANCER-04: 10 million euros
    • HORIZON-MISS-2027-02-CANCER-05: 26 million euros
    • HORIZON-MISS-2027-02-CANCER-06: 3 million euros
  • Amount of the grant: between 3 million euros and 10 million euros
  • Funding rate: between 70% and 100% of the total eligible costs

This grant is a lump sum grant (except for topics : HORIZON-MISS-2027-02-CANCER-01, HORIZON-MISS-2027-02-CANCER-05).